Mark Hamilton

Mark Hamilton serves as Assistant Professor in the Department of Lymphoma-Myeloma within the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center, Houston. His clinical focus centers on hematological malignancies through direct patient care and institutional research initiatives.

Research interests span blood cancer pathophysiology and therapeutic development, with emphasis on lymphoma and myeloma treatment protocols. His work integrates clinical practice with translational research to advance targeted therapies for hematologic cancers.

As a faculty member in MD Anderson's Cancer Medicine division, Dr. Hamilton participates in multidisciplinary tumor boards and institutional clinical trials infrastructure. His role bridges laboratory research with patient-centered oncology care within one of the world's leading cancer treatment centers.